Ketamine Completed Phase 4 Trials for Unipolar Depression / Depression, Bipolar Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01881763Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression